Ronald C Renaud Jr's Net Worth

$18.7 Million

Estimate Recalculated Nov 1, 2024 02:19PM EST

Who is Ronald C Renaud Jr

Ronald C Renaud Jr has an estimated net worth of $18.7 Million. This is based on reported shares across multiple companies, which include Atara Biotherapeutics, Inc., CHIMERIX INC, Ikena Oncology, Inc., PTC THERAPEUTICS, INC., Translate Bio, Inc., Akebia Therapeutics, Inc., Cerevel Therapeutics Holdings, Inc., IDENIX PHARMACEUTICALS INC, and KERYX BIOPHARMACEUTICALS INC.

SEC CIK

Ronald C Renaud Jr's CIK is 0001354434

Past Insider Trading and Trends

2021 was Ronald C Renaud Jr's most active year for acquiring shares with 8 total transactions. Ronald C Renaud Jr's most active month to acquire stocks was the month of May. 2014 was Ronald C Renaud Jr's most active year for disposing of shares, totalling 11 transactions. Ronald C Renaud Jr's most active month to dispose stocks was the month of July. 2015 saw Ronald C Renaud Jr paying a total of $612,000.00 for 26,000 shares, this is the most they've acquired in one year. In 2021 Ronald C Renaud Jr cashed out on 3,037,927 shares for a total of $19,122,778.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Atara Biotherapeutics, Inc.

Investor
Updated Jun 27, 2022
Form 4
472.73%
52.00K
Jun 27, 2022
63.00K
Grant
Jun 23
Form 4
28.50K
Jun 09, 2021
28.50K
Grant
Jun 08
Form 4
71.50K
Apr 30, 2020
71.50K
Grant
Apr 29
Form 3
Apr 30, 2020
Showing 4 results

CHIMERIX INC

Investor
Updated Jun 24, 2019
Form 4
21.00K
Jun 24, 2019
21.00K
Grant
Jun 20
Form 4
21.00K
Jun 21, 2018
21.00K
Grant
Jun 20
Form 4
21.00K
Jun 29, 2017
21.00K
Grant
Jun 28
Form 4
9.00K
Jun 28, 2016
9.00K
Grant
Jun 24
Form 4
9.00K
Jun 24, 2015
9.00K
Grant
Jun 22
Form 4
18.00K
Dec 18, 2014
18.00K
Grant
Dec 17
Form 3
Dec 18, 2014
Showing 7 results

Ikena Oncology, Inc.

Investor
Updated Jun 13, 2022
Form 4
13.42K
Jun 13, 2022
13.42K
Grant
Jun 09
Form 4
13.42K
Dec 23, 2021
13.42K
Grant
Dec 21
Form 3
Mar 25, 2021
Showing 3 results

PTC THERAPEUTICS, INC.

Investor
Updated Jan 05, 2017
Form 4
12.00K
Jan 05, 2017
12.00K
Grant
Jan 03
Form 4
12.00K
Jan 06, 2016
12.00K
Grant
Jan 04
Form 4
12.00K
$51.00
$612.00K
Jan 02, 2015
12.00K
Grant
Jan 02
Form 4
20.00K
$25.38
$507.60K
Jun 11, 2014
20.00K
Grant
Jun 10
Form 3
Jun 11, 2014
Showing 5 results

Translate Bio, Inc.

Chief Executive Officer
Updated Sep 14, 2021
Form 4
-100.00%
-3.47M
$38.00
-$36.25M
Sep 14, 2021
Sale
Sep 14
Form 4/A
$7.39
$66.70K
Sep 14, 2021
2.03M
Options
Apr 07
Form 4
$7.39
$66.70K
Apr 09, 2021
2.03M
Options
Apr 07
Form 4
325.00K
Mar 09, 2021
325.00K
Grant
Mar 09
Form 4
$7.39
$41.67K
Jan 14, 2021
2.12M
Options
Jan 14
Form 4
$7.39
$391.72K
Nov 18, 2020
2.12M
Options
Nov 16
Form 4
525.00K
Mar 05, 2020
525.00K
Grant
Mar 03
Form 4
500.00K
Mar 12, 2019
500.00K
Grant
Mar 08
Form 4
-45.26%
-372.73K
Jul 03, 2018
450.82K
Options
Jul 02
Form 3
Jun 27, 2018
804.56K
Showing 10 results

Akebia Therapeutics, Inc.

Investor
Updated Jun 15, 2018
Form 4
12.50K
Jun 15, 2018
12.50K
Grant
Jun 14
Form 4
12.50K
Jun 19, 2017
12.50K
Grant
Jun 15
Form 4
12.50K
Jun 20, 2016
12.50K
Grant
Jun 16
Form 4
5.00K
Jun 12, 2015
5.00K
Grant
Jun 10
Form 4
5.00K
$11.92
$59.59K
Dec 02, 2014
5.00K
Purchase
Dec 02
Form 4
10.00K
Sep 15, 2014
10.00K
Grant
Sep 12
Form 3
Sep 15, 2014
Showing 7 results

Cerevel Therapeutics Holdings, Inc.

President & CEO
Updated Jan 23, 2024
Form 4
284.02K
Jan 23, 2024
284.02K
Grant
Jan 19
Form 4
Dec 21, 2023
244.31K
Options
Dec 19
Form 4
83.86K
$23.96
$2.01M
Aug 07, 2023
83.86K
Purchase
Aug 03
Form 4
536.57K
Jun 14, 2023
536.57K
Grant
Jun 12
Form 3
Jun 14, 2023
Showing 5 results

IDENIX PHARMACEUTICALS INC

President & CEO
Updated Aug 05, 2014
Form 4
-100.00%
-2.36M
Aug 05, 2014
Disposition
Aug 05
Form 4
Jul 11, 2014
89.99K
Acq/Dis
Jun 04 - Jun 19
Form 4
400.00K
Feb 12, 2014
400.00K
Grant
Feb 11
Form 4
500.00K
Feb 22, 2013
500.00K
Grant
Feb 21
Form 4
$2.67
$199.98K
Dec 17, 2012
155.00K
Options
Dec 14
Form 4
375.00K
Mar 02, 2012
375.00K
Grant
Mar 01
Form 4
300.00K
Feb 23, 2011
300.00K
Grant
Feb 22
Form 4
300.00K
Nov 01, 2010
300.00K
Grant
Oct 28
Form 4
100.00K
Feb 11, 2010
100.00K
Grant
Feb 10
Form 4
110.00K
Feb 18, 2009
110.00K
Grant
Feb 13
Form 4
15.00K
Mar 11, 2008
15.00K
Purchase
Mar 11
Form 4
80.00K
Feb 26, 2008
80.00K
Grant
Feb 22
Form 4
40.00K
Nov 14, 2007
40.00K
Grant
Nov 09
Form 4
225.00K
Jul 02, 2007
225.00K
Grant
Jun 28
Form 3
Jul 02, 2007
Showing 15 results

KERYX BIOPHARMACEUTICALS INC

Chief Financial Officer
Updated Feb 16, 2007
Form 4
-5.97%
-5.97K
$11.79
-$70.42K
Feb 16, 2007
94.03K
Tax
Feb 14
Form 4
50.00K
Jan 04, 2007
50.00K
Grant
Dec 31
Form 3
Mar 03, 2006
100.00K
Showing 3 results

Upstream Bio, Inc.

Investor
Updated Oct 15, 2024
Form 4
17.10K
Oct 15, 2024
17.10K
Grant
Oct 10
Showing 1 results